Report cover image

Animal Healthcare Market (Animal Type: Bovine, Porcine, Ovine, and Poultry; Therapeutic Type: Drugs and Vaccines) - India Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031

Publisher Transparency Market Research Pvt. Ltd.
Published May 12, 2022
Length 250 Pages
SKU # TNPR17326563

Description

Animal Healthcare Market (Animal Type: Bovine, Porcine, Ovine, and Poultry; Therapeutic Type: Drugs and Vaccines) - India Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031

Companies Mentioned

Other prominent players
IDEXX Laboratories, Inc.
Virbac SA
Boehringer Ingelheim GmbH
Merial Ltd.
Ceva Sante Animale
Merck & Co. Inc.
Elanco Products Company
Bayer AG

Countries

India

Forecast Year (first) - 2022

Forecast Year (last) - 2031

Forecast Year ( first)  Value - 869.54

Forecast Year (last) Value - 1.36

CAGR % - 0.069

Currency - US$ Mn

Table of Contents

250 Pages
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: India Animal Healthcare Market
4. Market Overview
4.1. Introduction
4.1.1. Animal Type Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. India Animal Healthcare Market Analysis and Forecast, 2017–2031
4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
5.1. Key Vendor and Distributor Analysis
5.2. Regulatory Scenario, by Region/Globally
5.3. Key Industry Events (mergers, acquisitions, partnerships, etc.)
5.4. COVID-19 Pandemic Impact on Industry (value chain and short / mid / long term impact)
6. India Animal Healthcare Market Analysis and Forecast, by Animal Type
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Animal Type, 2017–2031
6.3.1. Bovine
6.3.2. Porcine
6.3.3. Ovine
6.3.4. Poultry
6.4. Market Attractiveness Analysis, by Animal Type
7. India Animal Healthcare Market Analysis and Forecast, by Therapeutic Type
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast, by Therapeutic Type, 2017–2031
7.3.1. Drugs
7.3.1.1. Analgesic
7.3.1.2. Antipyretic
7.3.1.3. Anti-inflammatory
7.3.1.4. Others
7.3.2. Vaccines
7.3.2.1. Live Attenuated
7.3.2.2. Inactivated Vaccine
7.3.2.3. Others
7.4. Market Attractiveness Analysis, by Therapeutic Type
8. India Animal Healthcare Market Analysis and Forecast, by Distribution Channel
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast, by Distribution Channel, 2017–2031
8.3.1. Veterinary Hospitals
8.3.2. Veterinary Clinics
8.3.3. Pharmacies
8.3.4. Others
8.4. Market Attractiveness Analysis, by Distribution Channel
9. India Animal Healthcare Market Analysis and Forecast, by Zone
9.1. Key Findings
9.2. Market Attractiveness Analysis, by Zone
10. India Animal Healthcare Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast, by Animal Type, 2017–2031
10.2.1. Bovine
10.2.2. Porcine
10.2.3. Ovine
10.2.4. Poultry
10.3. Market Value Forecast, by Therapeutic Type, 2017–2031
10.3.1. Drugs
10.3.1.1. Analgesic
10.3.1.2. Antipyretic
10.3.1.3. Anti-inflammatory
10.3.1.4. Others
10.3.2. Vaccines
10.3.2.1. Live Attenuated
10.3.2.2. Inactivated Vaccine
10.3.2.3. Others
10.4. Market Value Forecast, by Distribution Channel, 2017–2031
10.4.1. Veterinary Hospitals
10.4.2. Veterinary Clinics
10.4.3. Pharmacies
10.4.4. Others
10.5. Market Value Forecast, by Zone, 2017–2031
10.6. Market Attractiveness Analysis
10.6.1. By Animal Type
10.6.2. By Therapeutic Type
10.6.3. By Distribution Channel
10.6.4. By Zone
11. Competition Landscape
11.1. Market Player - Competition Matrix (by tier and size of companies)
11.2. Company Profiles
11.2.1. Bayer AG
11.2.1.1. Company Overview (HQ, Business Segments, Employee Strength)
11.2.1.2. Product Portfolio
11.2.1.3. Financial Overview
11.2.1.4. SWOT Analysis
11.2.1.5. Strategic Overview
11.2.2. Elanco Products Company
11.2.2.1. Company Overview (HQ, Business Segments, Employee Strength)
11.2.2.2. Product Portfolio
11.2.2.3. Financial Overview
11.2.2.4. SWOT Analysis
11.2.2.5. Strategic Overview
11.2.3. Merck & Co. Inc.
11.2.3.1. Company Overview (HQ, Business Segments, Employee Strength)
11.2.3.2. Product Portfolio
11.2.3.3. Financial Overview
11.2.3.4. SWOT Analysis
11.2.3.5. Strategic Overview
11.2.4. Ceva Sante Animale
11.2.4.1. Company Overview (HQ, Business Segments, Employee Strength)
11.2.4.2. Product Portfolio
11.2.4.3. Financial Overview
11.2.4.4. SWOT Analysis
11.2.4.5. Strategic Overview
11.2.5. Merial Ltd.
11.2.5.1. Company Overview (HQ, Business Segments, Employee Strength)
11.2.5.2. Product Portfolio
11.2.5.3. Financial Overview
11.2.5.4. SWOT Analysis
11.2.5.5. Strategic Overview
11.2.6. Boehringer Ingelheim GmbH
11.2.6.1. Company Overview (HQ, Business Segments, Employee Strength)
11.2.6.2. Product Portfolio
11.2.6.3. Financial Overview
11.2.6.4. SWOT Analysis
11.2.6.5. Strategic Overview
11.2.7. Virbac SA
11.2.7.1. Company Overview (HQ, Business Segments, Employee Strength)
11.2.7.2. Product Portfolio
11.2.7.3. Financial Overview
11.2.7.4. SWOT Analysis
11.2.7.5. Strategic Overview
11.2.8. IDEXX Laboratories, Inc.
11.2.8.1. Company Overview (HQ, Business Segments, Employee Strength)
11.2.8.2. Product Portfolio
11.2.8.3. Financial Overview
11.2.8.4. SWOT Analysis
11.2.8.5. Strategic Overview
11.2.9. Other prominent players
11.2.9.1. Company Overview (HQ, Business Segments, Employee Strength)
11.2.9.2. Product Portfolio
11.2.9.3. Financial Overview
11.2.9.4. SWOT Analysis
11.2.9.5. Strategic Overview

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us